Los Angeles Capital Management’s OptimizeRx OPRX Stock Holding History

Los Angeles Capital Management’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$99.6K	Sell	15,866 -28,711	-64%	-$267K	﹤0.01%	1336
2025 Q4	$874K	Sell	44,577 -3,913	-8%	-$63.9K	﹤0.01%	682
2025 Q3	$994K	Buy	48,490 +22,667	+88%	+$360K	﹤0.01%	707
2025 Q2	$349K	Buy	+25,823	New	+$282K	﹤0.01%	996
2023 Q4	–	Sell	-29,782	Closed	-$232K	–	1211
2023 Q3	$232K	Buy	29,782 +5,530	+23%	+$60.2K	﹤0.01%	1034
2023 Q2	$347K	Buy	24,252 +700	+3%	+$9.97K	﹤0.01%	957
2023 Q1	$345K	Sell	23,552 -600	-2%	-$10K	﹤0.01%	967
2022 Q4	$406K	Sell	24,152 -46,900	-66%	-$811K	﹤0.01%	948
2022 Q3	$1.05M	Buy	71,052 +18,240	+35%	+$361K	0.01%	679
2022 Q2	$1.45M	Buy	+52,812	New	+$1.56M	0.01%	612

Other funds holding OPRX

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Los Angeles Capital Management's OPRX Position: Q1 2026 in Review

Los Angeles Capital Management reduced its OptimizeRx (OPRX) stake by 64% in Q1 2026, selling an estimated $267K and leaving 15,866 shares worth $99.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1336.

Los Angeles Capital Management first reported a position in OPRX in Q2 2022 and has held it in 10 quarters since. The position peaked at $1.45M in Q2 2022. 127 funds tracked by Wall St. Rank hold OPRX as of Q1 2026.

Los Angeles Capital Management held 15,866 shares of OptimizeRx worth $99.6K as of Q1 2026.
Los Angeles Capital Management sold 28,711 OptimizeRx shares in Q1 2026, an estimated $267K.
OptimizeRx made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #1336 holding.
Los Angeles Capital Management first reported a position in OptimizeRx in Q2 2022 and has held it in 10 quarters since.
Los Angeles Capital Management's OptimizeRx position peaked at $1.45M in Q2 2022.
127 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.